Amneal Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMRX and other ETFs, options, and stocks.About AMRX
Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog.
AMRX Key Statistics
Stock Snapshot
With a market cap of 3.67B, Amneal Pharmaceuticals(AMRX) trades at $11.69. The stock has a price-to-earnings ratio of 811.81.
Amneal Pharmaceuticals(AMRX) stock opened on 2025-11-06 at $11.33. The price climbed to — and dipped to —.
The Amneal Pharmaceuticals(AMRX)'s current trading volume is 0, compared to an average daily volume of 1.87M.
In the last year, Amneal Pharmaceuticals(AMRX) shares hit a 52-week high of $11.74 and a 52-week low of $6.69.
In the last year, Amneal Pharmaceuticals(AMRX) shares hit a 52-week high of $11.74 and a 52-week low of $6.69.
AMRX News
Amneal Pharmaceuticals (AMRX) has posted a standout earnings outlook, with net income projected to grow at a rapid 80.1% per year for the next three years, far...
Amneal Pharma ((AMRX)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks P...
Piper Sandler raised the firm’s price target on Amneal Pharmaceuticals (AMRX) to $13 from $11 and keeps an Overweight rating on the shares. The firm notes Amnea...
More AMRX News
Amneal Pharma ( (AMRX) ) has released its Q3 earnings. Here is a breakdown of the information Amneal Pharma presented to its investors. Elevate Your Investing S...
Amneal Pharmaceuticals, Inc. reported strong third-quarter 2025 results, returning to profitability with US$784.51 million in sales and launching new products,...